Analysis

McDonald’s (MCD) looks poised to report higher Q3 2024 revenue and profit

Fast food chain McDonald's Corporation (NYSE: MCD) delivered unimpressive sales performance in the early half of the year, reflecting cautious consumer spending

Starbucks’ (SBUX) Q4 2024 performance hurt by weakness across major markets

Shares of Starbucks Corporation (NASDAQ: SBUX) remained in red on Wednesday after the company issued disappointing preliminary results for the fourth quarter

Important takeaways from Netflix’s (NFLX) Q3 2024 report

Netflix, Inc. (NASDAQ: NFLX) has reported stronger-than-expected revenue, earnings, and subscriber numbers for the third quarter. Over the years, the video-streaming giant

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Boeing (BA) Q3 2024 Earnings: Key financials and quarterly highlights

The Boeing Company (NYSE: BA) reported its third quarter 2024 earnings results today. Revenues dipped 1% year-over-year to $17.8 billion. Net loss attributable to Boeing shareholders was $6.17 billion, or

October 23, 2024

KO Earnings: Coca-Cola Q3 adjusted profit rises and beats Street view

Soft drink giant The Coca-Cola Company (NYSE: KO) reported an increase in adjusted earnings for the third quarter of 2024. Earnings also exceeded analysts’ estimates. Earnings, adjusted for special items,

October 23, 2024

T Earnings: All you need to know about AT&T’s Q3 2024 earnings results

AT&T Inc. (NYSE: T) reported its third quarter 2024 earnings results today. Revenues totaled $30.2 billion versus $30.4 billion in the year-ago quarter. Net loss attributable to common stock was

October 23, 2024

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top